{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:03:03Z","timestamp":1792112583780,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.molimm.2023.03.017","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T13:38:16Z","timestamp":1680701896000},"page":"146-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Bone marrow mesenchymal stem cell-derived exosomes alleviate skin fibrosis in systemic sclerosis by inhibiting the IL-33\/ST2 axis via the delivery of microRNA-214"],"prefix":"10.1016","volume":"157","author":[{"given":"Lihu","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meili","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2023.03.017_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13075-017-1331-z","article-title":"Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis","volume":"19","author":"Artlett","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.molimm.2023.03.017_bib2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/1346-8138.14153","article-title":"Systemic sclerosis","volume":"45","author":"Asano","year":"2018","journal-title":"J. Dermatol."},{"key":"10.1016\/j.molimm.2023.03.017_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103283","article-title":"Decreased miR-214-3p activates NF-kappaB pathway and aggravates osteoarthritis progression","volume":"65","author":"Cao","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.molimm.2023.03.017_bib4","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.molimm.2023.03.017_bib5","doi-asserted-by":"crossref","first-page":"3858032","DOI":"10.1155\/2018\/3858032","article-title":"IL-33\/IL-31 axis: a potential inflammatory pathway","volume":"2018","author":"Di Salvo","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.molimm.2023.03.017_bib6","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1080\/14397595.2020.1859726","article-title":"Serum protein levels of YKL-40 and plasma miR-214 expression in patients with systemic sclerosis","volume":"31","author":"Dichev","year":"2021","journal-title":"Mod. Rheuma"},{"key":"10.1016\/j.molimm.2023.03.017_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102831","article-title":"Human mesenchymal stem cells for the management of systemic sclerosis. Systematic review","volume":"20","author":"Escobar-Soto","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.molimm.2023.03.017_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102755","article-title":"Mesenchymal stromal cells for systemic sclerosis treatment","volume":"20","author":"Farge","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.molimm.2023.03.017_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006957","article-title":"Down-regulation of microRNA-203-3p initiates type 2 pathology during schistosome infection via elevation of interleukin-33","volume":"14","author":"He","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molimm.2023.03.017_bib10","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jid.2017.01.011","article-title":"Bone marrow-derived mesenchymal stem cells expressing thioredoxin 1 attenuate bleomycin-induced skin fibrosis and oxidative stress in scleroderma","volume":"137","author":"Jiang","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.molimm.2023.03.017_bib11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s13287-021-02400-y","article-title":"BMSC-derived extracellular vesicles intervened the pathogenic changes of scleroderma in mice through miRNAs","volume":"12","author":"Jin","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.molimm.2023.03.017_bib12","first-page":"5","article-title":"Interstitial microRNA miR-214 attenuates inflammation and polycystic kidney disease progression","author":"Lakhia","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.molimm.2023.03.017_bib13","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1089\/ars.2019.7965","article-title":"Mesenchymal stem cell-derived extracellular vesicles attenuate radiation-induced lung injury via miRNA-214-3p","volume":"35","author":"Lei","year":"2021","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.molimm.2023.03.017_bib14","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.3389\/fimmu.2018.02663","article-title":"Interleukin-33 in systemic sclerosis: expression and pathogenesis","volume":"9","author":"Li","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2023.03.017_bib15","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.autrev.2017.05.024","article-title":"The role of endothelial cells in the vasculopathy of systemic sclerosis: a systematic review","volume":"16","author":"Mostmans","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.molimm.2023.03.017_bib16","first-page":"20","article-title":"IL-33\/IL-31 axis in immune-mediated and allergic diseases","author":"Murdaca","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molimm.2023.03.017_bib17","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.bbamem.2018.03.013","article-title":"PKH26 labeling of extracellular vesicles: characterization and cellular internalization of contaminating PKH26 nanoparticles","volume":"1860","author":"Puzar Dominkus","year":"2018","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.molimm.2023.03.017_bib18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/19768354.2021.1995486","article-title":"Mirodenafil ameliorates skin fibrosis in bleomycin-induced mouse model of systemic sclerosis","volume":"25","author":"Roh","year":"2021","journal-title":"Anim. Cells Syst."},{"key":"10.1016\/j.molimm.2023.03.017_bib19","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.3389\/fimmu.2018.02938","article-title":"Mesenchymal stem cells in systemic sclerosis: allogenic or autologous approaches for therapeutic use?","volume":"9","author":"Rozier","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2023.03.017_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102660","article-title":"Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p","volume":"121","author":"Rozier","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.molimm.2023.03.017_bib21","first-page":"716","article-title":"Systemic sclerosis - the dermatological perspective","volume":"17","author":"Sticherling","year":"2019","journal-title":"J. Dtsch Dermatol. Ges."},{"key":"10.1016\/j.molimm.2023.03.017_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.663381","article-title":"Editorial: etiopathogenesis of systemic sclerosis: an update","volume":"12","author":"Stifano","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2023.03.017_bib23","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1042\/CS20170098","article-title":"Cytokines of the IL-1 family: recognized targets in chronic inflammation underrated in organ transplantations","volume":"131","author":"Striz","year":"2017","journal-title":"Clin. Sci."},{"key":"10.1016\/j.molimm.2023.03.017_bib24","doi-asserted-by":"crossref","first-page":"4506303","DOI":"10.1155\/2019\/4506303","article-title":"Exosomal miRNA Let-7 from menstrual blood-derived endometrial stem cells alleviates pulmonary fibrosis through regulating mitochondrial DNA damage","volume":"2019","author":"Sun","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.molimm.2023.03.017_bib25","first-page":"9","article-title":"Novel concepts in systemic sclerosis pathogenesis: role for miRNAs","author":"Szabo","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.molimm.2023.03.017_bib26","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1136\/annrheumdis-2018-214865","article-title":"Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease","volume":"78","author":"Valenzi","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molimm.2023.03.017_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.825567","article-title":"IL-13 and IL-33 serum levels are increased in systemic sclerosis patients with interstitial lung disease","volume":"9","author":"Versace","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.molimm.2023.03.017_bib28","first-page":"2229","article-title":"miR214 mediates vascular inflammation and apoptosis via PTEN expression","volume":"18","author":"Wang","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.molimm.2023.03.017_bib29","first-page":"2332","article-title":"Inhibition of miR-214-5p attenuates inflammatory chemotaxis and nerve regeneration obstruction after spinal cord injury in rats","volume":"23","author":"Wang","year":"2019","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"10.1016\/j.molimm.2023.03.017_bib30","first-page":"357","article-title":"Exosomal miR-214 from endometrial stromal cells inhibits endometriosis fibrosis","volume":"24","author":"Wu","year":"2018","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.molimm.2023.03.017_bib31","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2019-215208","article-title":"Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis","volume":"78","author":"Wu","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molimm.2023.03.017_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117746","article-title":"TM4SF1 involves in miR-1-3p\/miR-214-5p-mediated inhibition of the migration and proliferation in keloid by regulating AKT\/ERK signaling","volume":"254","author":"Xu","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.molimm.2023.03.017_bib33","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1042\/CS20190203","article-title":"The deficiency of miR-214-3p exacerbates cardiac fibrosis via miR-214-3p\/NLRC5 axis","volume":"133","author":"Yang","year":"2019","journal-title":"Clin. Sci."},{"key":"10.1016\/j.molimm.2023.03.017_bib34","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1007\/s10753-021-01503-1","article-title":"miR-483-3p promotes IL-33 production from fibroblast-like synoviocytes by regulating ERK signaling in rheumatoid arthritis","volume":"44","author":"Zhang","year":"2021","journal-title":"Inflammation"},{"key":"10.1016\/j.molimm.2023.03.017_bib35","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/annrheumdis-2020-216963","article-title":"PGC-1alpha regulates autophagy to promote fibroblast activation and tissue fibrosis","volume":"79","author":"Zhang","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molimm.2023.03.017_bib36","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12931-021-01883-w","article-title":"Knockdown of circFOXO3 ameliorates cigarette smoke-induced lung injury in mice","volume":"22","author":"Zhou","year":"2021","journal-title":"Respir. Res."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589023000652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589023000652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:47:32Z","timestamp":1758980852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589023000652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":36,"alternative-id":["S0161589023000652"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2023.03.017","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone marrow mesenchymal stem cell-derived exosomes alleviate skin fibrosis in systemic sclerosis by inhibiting the IL-33\/ST2 axis via the delivery of microRNA-214","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2023.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}